Original Research Online Published: 30 Jul 2021 | ||||||||||||
Clinical outcome in coronavirus disease patients treated with tocilizumab at a dedicated COVID hospital: A retrospective observational study Teli Shaikh Emaran Shaikh Ismail, Jaiprakash Ramanand, Rajshree Netram Mandhare, Chetan Suresh Bhangale.
|
How to Cite this Article |
Pubmed Style Ismail TSES, Ramanand J, Mandhare RN, Bhangale CS. Clinical outcome in coronavirus disease patients treated with tocilizumab at a dedicated COVID hospital: A retrospective observational study. Natl J Physiol Pharm Pharmacol. 2021; 11(9): 1060-1063. doi:10.5455/njppp.2021.11.05156202105062021 Web Style Ismail TSES, Ramanand J, Mandhare RN, Bhangale CS. Clinical outcome in coronavirus disease patients treated with tocilizumab at a dedicated COVID hospital: A retrospective observational study. https://www.njppp.com/?mno=82774 [Access: January 08, 2025]. doi:10.5455/njppp.2021.11.05156202105062021 AMA (American Medical Association) Style Ismail TSES, Ramanand J, Mandhare RN, Bhangale CS. Clinical outcome in coronavirus disease patients treated with tocilizumab at a dedicated COVID hospital: A retrospective observational study. Natl J Physiol Pharm Pharmacol. 2021; 11(9): 1060-1063. doi:10.5455/njppp.2021.11.05156202105062021 Vancouver/ICMJE Style Ismail TSES, Ramanand J, Mandhare RN, Bhangale CS. Clinical outcome in coronavirus disease patients treated with tocilizumab at a dedicated COVID hospital: A retrospective observational study. Natl J Physiol Pharm Pharmacol. (2021), [cited January 08, 2025]; 11(9): 1060-1063. doi:10.5455/njppp.2021.11.05156202105062021 Harvard Style Ismail, T. S. E. S., Ramanand, . J., Mandhare, . R. N. & Bhangale, . C. S. (2021) Clinical outcome in coronavirus disease patients treated with tocilizumab at a dedicated COVID hospital: A retrospective observational study. Natl J Physiol Pharm Pharmacol, 11 (9), 1060-1063. doi:10.5455/njppp.2021.11.05156202105062021 Turabian Style Ismail, Teli Shaikh Emaran Shaikh, Jaiprakash Ramanand, Rajshree Netram Mandhare, and Chetan Suresh Bhangale. 2021. Clinical outcome in coronavirus disease patients treated with tocilizumab at a dedicated COVID hospital: A retrospective observational study. National Journal of Physiology, Pharmacy and Pharmacology, 11 (9), 1060-1063. doi:10.5455/njppp.2021.11.05156202105062021 Chicago Style Ismail, Teli Shaikh Emaran Shaikh, Jaiprakash Ramanand, Rajshree Netram Mandhare, and Chetan Suresh Bhangale. "Clinical outcome in coronavirus disease patients treated with tocilizumab at a dedicated COVID hospital: A retrospective observational study." National Journal of Physiology, Pharmacy and Pharmacology 11 (2021), 1060-1063. doi:10.5455/njppp.2021.11.05156202105062021 MLA (The Modern Language Association) Style Ismail, Teli Shaikh Emaran Shaikh, Jaiprakash Ramanand, Rajshree Netram Mandhare, and Chetan Suresh Bhangale. "Clinical outcome in coronavirus disease patients treated with tocilizumab at a dedicated COVID hospital: A retrospective observational study." National Journal of Physiology, Pharmacy and Pharmacology 11.9 (2021), 1060-1063. Print. doi:10.5455/njppp.2021.11.05156202105062021 APA (American Psychological Association) Style Ismail, T. S. E. S., Ramanand, . J., Mandhare, . R. N. & Bhangale, . C. S. (2021) Clinical outcome in coronavirus disease patients treated with tocilizumab at a dedicated COVID hospital: A retrospective observational study. National Journal of Physiology, Pharmacy and Pharmacology, 11 (9), 1060-1063. doi:10.5455/njppp.2021.11.05156202105062021 |